Brand Name Drugs Rise in Price; Generics Go Down
Tuesday, June 08, 2010
![Brand Name Drugs Rise in Price; Generics Go Down](http://www.allgov.com/user_content/newsimages/8102c073-287d-43b0-a547-1639c4036d4c.jpeg?app=278)
While Congress struggled to adopt national healthcare reform throughout last year and into the beginning of 2010, pharmaceutical manufacturers continued to hike the price of name-brand medications.
An analysis of drug prices by the AARP Public Policy Institute revealed that brand name drugs rose more than 9% from March 2009 to March 2010—despite the fact that inflation was close to zero for consumer goods.
Some individual medications rocketed even higher during the one-year period under review. Flomax, for example, leaped 27.6% in cost.
Although brand name pharmaceuticals went up in price, generic drugs fell by an average of 9%.
-David Wallechinsky
Brand Name and Specialty Drug Prices Continue to Climb (Rx Watchdog Report, AARP) (pdf)
- Top Stories
- Unusual News
- Where is the Money Going?
- Controversies
- U.S. and the World
- Appointments and Resignations
- Latest News
- Can Biden Murder Trump and Get Away With it?
- Electoral Advice for the Democratic and Republican Parties
- U.S. Ambassador to Greece: Who is George Tsunis?
- Henry Kissinger: A Pre-Obituary
- U.S. Ambassador to Belize: Who is Michelle Kwan?
Comments